Medical Devices Pre-Seed Investors & VC Firms
555 firms in this list, with a median first check of $300K. 137 of them lead rounds. Generated from verified public data and updated continuously.
Waarde Capital
CapellenPre-Seed–Late Stage$15M
5 people
Archetype Ventures
TokyoPre-Seed–Growth$875K – $92M
6 people
ETCapital
CambridgePre-Seed–Series A$100K – $952.5K
3 people
Julian Capital
AustinPre-Seed–Seed$400K – $2M
3 people
TusStar
BeijingPre-Seed–Growth
Unfold Ventures
WrocławPre-Seed–Late Stage$110K – $1.1M
7 people
Intelligence Ventures
Pre-Seed–Seed$50K
6 people
Launch Capital
TorontoPre-Seed–Growth
3 people
Red Bike Capital
New YorkPre-Seed–Series A$25K – $1M
2 people
Zühlke Ventures
ZurichPre-Seed–Series A$165K – $275K
2 people
Arches Capital
Pre-Seed–Series A$270K – $1.1M
7 people
BayMed Venture Partners
San FranciscoPre-Seed–Series B
7 people
ExSight Ventures
New YorkPre-Seed–Series B
4 people
Magnivia Ventures
New JerseyPre-Seed–Series B$250K – $750K
7 people
TiVenture SA
LuganoPre-Seed–Series B
4 people
AZ Venture Capital Inc.
PhoenixPre-Seed–Series B
5 people
Investo Capital
AalborgPre-Seed–Series A$30K – $3M
5 people
Pathway Bioventures
ChicagoPre-Seed–Series A
5 people
Louisiana Funds
Baton RougePre-Seed–Series A
4 people
Cap70
MumbaiPre-Seed–Series A
9 people
HBM Partners
ZugPre-Seed–Late Stage$5M – $50M
6 people
CWRU Technology Ventures
ClevelandPre-Seed–Seed$50K – $250K
1 person
Prana Tech Ventures
New YorkPre-Seed–Seed
4 people
Venture
ZurichPre-Seed–Series B
10 people
Related lists
Pre-Seed Investors & VC Firms (5910)Pre-Seed Investors & VC Firms in North America (3177)Pre-Seed Investors & VC Firms in United States (2829)AI & Machine Learning Pre-Seed Investors & VC Firms (1978)SaaS Pre-Seed Investors & VC Firms (1723)Pre-Seed Investors & VC Firms in Europe (1666)Fintech Pre-Seed Investors & VC Firms (1626)Pre-Seed Investors & VC Firms in Global (1563)Healthtech Pre-Seed Investors & VC Firms (1457)Medical Devices Investors & VC Firms (1452)
Data sourced from public filings and firms' own websites — see our methodology.
































































